beta
Text
1. The plaintiff's appeal is dismissed.
2. The costs of appeal shall be borne by the Plaintiff.
The purport of the claim and appeal is the purport of the appeal.
Reasons
1. Basic facts
A. On March 15, 2010, the Plaintiff concluded a contract for construction works (hereinafter “instant construction contract”) on December 16, 2010, with respect to the installation and operation of the “cudio” facilities for manufacturing the Busan Shipping Daegu D or 714 (hereinafter “Scudio”) with the Defendant operating the “E” as a corporation established for the purpose of engaging in the manufacturing of drugs, etc., and concluded an experimental service contract (hereinafter “instant service contract”) with the following contents on December 21, 2010:
(hereinafter hereinafter referred to as “each of the instant contracts”). The date of completion of the construction contract: The name of the ordering company under Article 1(1) of the Construction Contract: Plaintiff 2: the date of completion of the construction project: December 004: Within 35 days after the order: the method of payment under Article 3 (1) of the construction cost of Article 2 ( within the period of 35,000,000 (VT separate; hereinafter the same shall apply): The date of the contract (as of December 00: 18,00,000 won and the equipment of the Defendant’s disposal of equipment: 30% of cash at the time of the completion of the construction project; 13,500,000 won and the date of completion of the construction project: 30% of cash at the time of the construction project; 13,500,000 won and the date of completion of the construction project; 2) the details of the construction project at the time of the first change: 2) the installation of the equipment installation of the estimate.
2) In the event that the designated material is unable to be supplied due to unavoidable reasons, it may be constructed with the Plaintiff’s approval on the line that is not at issue on the part of obtaining certification for the manufacture quality control of medicine from the GPM Food and Drug Administration.